Research and clinical insight from Apollo Medicine

About the Journal

Apollo Medicine is associated with Apollo Hospitals, founded by Dr. Prathap C. Reddy in 1983, and is published in association with Elsevier. The journal carries the ISSN 0976-0016 and makes issues and individual articles available through ScienceDirect for institutional and personal access.

The Apollo Medicine journal serves as a dedicated platform for advancing clinical knowledge and healthcare research. Published in association with Elsevier, it bridges the gap between academic inquiry and bedside practice, offering a curated selection of articles that reflect the evolving landscape of modern medicine. The journal draws on the extensive clinical experience of a major hospital network, ensuring that its content remains grounded in real-world patient care and contemporary medical challenges.

Each issue of Apollo Medicine presents a diverse range of contributions, from original research papers and case reports to review articles and clinical perspectives. The editorial board places a strong emphasis on rigorous peer review and scientific integrity, fostering a scholarly environment where new findings can be shared and debated. By covering multiple specialties under one banner, the journal encourages cross-disciplinary dialogue and helps clinicians stay informed about developments beyond their immediate field of practice.

A recurring theme across published volumes is the management of acute and critical conditions. Topics such as sepsis, acute stroke, and renal failure feature prominently, reflecting the high-stakes nature of hospital-based medicine. Articles in this domain explore diagnostic biomarkers, therapeutic protocols, and prognostic indicators, aiming to equip physicians with evidence-based strategies for improving outcomes in time-sensitive clinical scenarios where early recognition and intervention can make a decisive difference.

Infectious disease remains a cornerstone of the journal's scope, with particular attention to conditions that present diagnostic challenges. Reports on tuberculosis, including unusual manifestations such as endobronchial presentations, highlight the importance of maintaining a broad differential diagnosis. These contributions underscore how atypical presentations can mimic other illnesses, reminding clinicians that vigilance and thorough investigation are essential components of effective patient assessment and treatment planning.

The journal also dedicates significant space to chronic and autoimmune conditions, exploring both established therapies and emerging treatment paradigms. Studies examining the efficacy and safety of cyclophosphamide, as well as discussions on pemphigus remission, illustrate the ongoing effort to balance therapeutic benefit with potential morbidity. Such articles provide valuable guidance for clinicians managing complex, long-term conditions that require sustained and carefully monitored treatment strategies.

Surgical innovation and interventional procedures form another vital strand of the journal's content. Case reports detailing arthroscopic retrieval of foreign bodies, such as a bullet from the knee joint, demonstrate the precision and problem-solving inherent in modern surgical practice. These accounts not only document technical achievements but also contribute to the collective knowledge base that informs surgical decision-making and postoperative care in trauma and orthopaedic settings.

Respiratory medicine and pulmonary pathology receive thoughtful coverage, with articles addressing hypoxic respiratory failure, total lung involvement in various diseases, and the role of imaging in diagnosis. The journal examines how chest imaging, combined with clinical assessment, can reveal tissue-level changes that guide management. This focus on pulmonary conditions reflects the importance of respiratory health across multiple patient populations and the need for nuanced understanding of lung function and dysfunction.

Preventive medicine and the role of pharmacological agents in averting disease progression are explored through discussions on methylxanthines and adenosine. By examining how these compounds influence physiological pathways, the journal contributes to a broader conversation about preventing common conditions before they escalate. The inclusion of research on irisin and type-related metabolic markers further signals an interest in the molecular underpinnings of health and disease, linking basic science to clinical relevance.

As a publication with roots in the Indian healthcare system, Apollo Medicine offers valuable perspectives on medical practice in a rapidly developing country. The journal acknowledges the unique challenges and opportunities present in such settings, where a high burden of both communicable and non-communicable diseases coexists. By providing a platform for local research and clinical experience, it contributes to the global medical literature while addressing regionally relevant healthcare priorities and fostering professional growth among clinicians.

Submitting to Apollo Medicine

Prospective contributors can submit manuscripts through the Elsevier Editorial System at ees.elsevier.com/apme/. Author information, permissions guidance, and editorial board details are available for reference before submission.